E. R. Maher, A. R. Webster, F. M. Richards, J. S. Green, P. A. Crossey, S. J. Payne, and A. T. Moore, (1996) Phenotypic expression in von Hippel-Lindau disease: Correlations with germline VHL gene mutations, J. Med. Genet., 33, 328-332.
 F. M. Richards, S. J. Payne, B. Zbar, N. A. Affara, M. A. Ferguson-Smith, and E. R. Maher, (1995) Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene, Hum. Mol. Genet., 4, 2139-2143.
 P. O. Schnell, M. L. Ignacak, A. L. Bauer, J. B. Striet, W. R. Paulding, and M. F. Czyzyk-Krzeska, (2003) Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors, J. Neurochem., 85, 483-491.
 T. Shuin, I. Yamasaki, K. Tamura, H. Okuda, M. Furihata, and S. Ashida, (2006) Von Hippel-Lindau disease: Molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment, Jpn. J. Clin. Oncol., 36, 337-343.
 F. Chen, T. Kishida, M. Yao, T. Hustad, D. Glavac, M. Dean, J. R. Gnarra, M. L. Orcutt, F. M. Duh, G. Glenn, J. Green, Y. E. Hsia, J. Lamiell, H. Li, M. H. Wei, L. Schmidt, K. Tory, I. Kuzmin, T. Stackhouse, F. Latif, W. M. Linehan, M. Lerman, and B. Zbar, (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype, Hum. Mutat., 5, 66-75.
 S. Lee, E. Nakamura, H. Yang, W. Wei, M. S. Linggi, M. P. Sajan, R. V. Farese, R. S. Freeman, B. D. Carter, W. G. Jr. Kaelin, and S. Schlisio, (2005) Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial phaeochromocytoma genes: developmental culling and cancer. Cancer Cell, 8, 1-13.
 S. Olschwang, S. Richard, C. Boisson, S. Giraud, P. Laurent- Puig, F. Resche, and G. Thomas, (1998) Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma, Hum. Mutat., 12, 424-430.
 C. Stolle, G. Glenn, B. Zbar, J. S. Humphrey, P. Choyke, M. Walther, S. Pack, K. Hurley, C. Andrey, R. Klausner, and W. M. Linehan, (1998) Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene, Hum. Mutat., 12, 417-423.
 G. Wu and S. Yan, (2000) Prediction of distributions of amino acids and amino acid pairs in human haemoglobin ?-chain and its seven variants causing-thalassemia from their occurrences according to the random mechanism, Comp. Haematol. Int, 10, 80-84.
 G. Wu and S. Yan, (2001) Analysis of distributions of amino acids, amino acid pairs and triplets in human insulin precursor and four variants from their occurrences according to the random mechanism, J. Biochem. Mol. Biol. Biophys., 5, 293-300.
 G. Wu and S. Yan, (2001) Analysis of distributions of amino acids and amino acid pairs in human tumor necrosis factor precursor and its eight variants according to random mechanism, J. Mol. Model, 7, 318-323.
 G. Wu and S. Yan, (2002) Random analysis of presence and absence of two-and three-amino-acid sequences and distributions of amino acids, two- and three-amino-acid sequences in bovine p53 protein, Mol. Biol. Today, 3, 31-37.
 G. Wu and S. Yan, (2002) Analysis of distributions of amino acids in the primary structure of apoptosis regulator Bcl-2 family according to the random mechanism, J. Biochem. Mol. Biol. Biophys, 6, 407-414.
 G. Wu and S. Yan, (2005) Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis, Biochem. Biophys. Res. Commun., 326, 475-482.
 G. Wu and S. Yan, (2007) Improvement of model for prediction of hemagglutinin mutations in H5N1 influenza viruses with distinguishing of arginine, leucine and serine, Protein Pept. Lett., 14, 191-196.
 G. Wu and S. Yan, (2007) Improvement of prediction of mutation positions in H5N1 hemagglutinins of influenza A virus using neural network with distinguishing of arginine, leucine and serine, Protein Pept. Lett., 14, 465-470.
 B. Zbar, T. Kishida, F. Chen, L. Schmidt, E. R. Maher, F. M. Richards, P. A. Crossey, A. R. Webster, N. A. Affara, M. A. Ferguson-Smith, et al., (1996) Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan, Hum. Mutat., 8, 348-357.
 S. O. Ang, H. Chen, K. Hirota, V. R. Gordeuk, J. Jelinek, Y. Guan, E. Liu, A. I. Sergueeva, G. Y. Miasnikova, D. Mole, P. H. Maxwell, D. W. Stockton, G. L. Semenza, and J. T. Prchal., (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia, Nature Genet., 32, 614-621.
 Y. Pastore, K. Jedlickova, Y. Guan, E. Liu, J. Fahner, H. Hasle, J. F. Prchal, and J. T. Prchal., (2003) Mutations of von Hippel- Lindau tumor-suppressor gene and congenital polycythemia, Am. J. Hum. Genet., 73, 412-419.
 M. T. Sgambati, C. Stolle, P. L. Choyke, M. M. Walther, B. Zbar, W. M. Linehan, and G. M. Glenn, (2000) Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents, Am. J. Hum. Genet., 66, 84-91.
 A. R. Webster, F. M. Richards, F. E. MacRonald, A. T. Moore, and E. R. Maher, (1998) An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects, Am. J. Hum. Genet., 63, 1025-1035.
 P. A. Crossey, C. Eng, M. Ginalska-Malinowska, T. W. J. Lennard, J. R. Sampson, B. A. J. Ponder, and E. R. Maher, (1995) Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma, J. Med. Genet., 32, 885-886.
 P. A. Crossey, F. M. Richards, K. Foster, J. S. Green, A. Prowse, F. Latif, M. I. Lerman, B. Zbar, N. A. Affara, M. A. Ferguson-Smith, and R. Maher, (1994) Buys CHCM, identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype, Hum. Mol. Genet., 3, 1303-1308.
 E. R. Maher, A. R. Webster, F. M. Richards, J. S. Green, P. A. Crossey, S. J. Payne, and A. T. Moore, (2000) Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations, J. Med. Genet., 37, 62-63.
 G. Wu and S. Yan, (2007) Translation probability between RNA codons and translated amino acids, and its applications to protein mutations, in: Leading-Edge Messenger RNA Research Communications, ed. Ostrovskiy M. H. Nova Science Publishers, New York, Chapter 3, 47-65.